Clinical trials
Recruiting Adenocarcinoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imperial College London | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| AstraZeneca | 1 |
| East and North Hertfordshire NHS Trust | 1 |
| Eisai Inc. | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Turning Point Therapeutics, Inc. | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 9 |
| Neoplasms | 5 |
| Prostatic Neoplasms | 3 |
| Carcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Bronchial Neoplasms | 1 |
| Carcinoma, Bronchogenic | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Colonic Diseases | 1 |
| Colonic Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.